Preventing Cognitive Decline
Modulation Effects of a Novel Body-mind Intervention on Subjective Cognitive Decline
2 other identifiers
interventional
40
1 country
1
Brief Summary
The study aims to understand the mechanisms and training effects of evidence-based body-mind training on improving cognitive performance and preventing cognitive decline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 25, 2022
CompletedFirst Posted
Study publicly available on registry
July 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2023
CompletedResults Posted
Study results publicly available
October 29, 2024
CompletedOctober 29, 2024
October 1, 2024
2.1 years
May 25, 2022
March 26, 2024
October 3, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Percentage of Trials Correct On Working Memory Test
The percentage of trials correct on N-back working memory test; higher percentage of trials correct mean a better outcome.
The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).
Intervention Effects on Cognitive Decline
The composite measures of cognition such as subjective cognitive decline; the minimum and maximum values (1 and 27); higher scores mean a worse outcome.
The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).
Intervention Effects on Emotion Regulation
The composite measures of executive function such as emotion regulation questionnaire; the minimum and maximum values (4 and 10); higher scores mean a better outcome.
The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).
Intervention Effects on Mindfulness
The composite measures of executive function such as Five Facet Mindfulness Questionnaire; the minimum and maximum values (1 and 5); higher scores mean a better outcome.
The outcome measures are assessed online or/and in-person at baseline and post-intervention (2 weeks).
Secondary Outcomes (3)
Intervention Effects on Brain Function
The outcome measures are assessed in-person at baseline and post-intervention (2 weeks).
Intervention Effects on Brain White Matter
The outcome measures are assessed in-person at baseline and post-intervention (2 weeks).
Intervention Effects on Brain Grey Matter
The outcome measures are assessed in-person at baseline and post-intervention (2 weeks).
Study Arms (2)
IBMT mindfulness
EXPERIMENTALAn evidence-based preventive intervention - integrative body-mind training (IBMT) has shown positive effects in reducing stress, and improving self-control and brain plasticity related to cognitive performance. It has bodifulness and mindfulness components.
health education
ACTIVE COMPARATORHealth education includes health-related topics - exercise, sleep, stress management, nutrition, lifestyle
Interventions
IBMT is an effortless mindfulness technique; health education is a class including health-related topics - exercise, sleep, nutrition, lifestyle, stress management
Health education includes health-related topics - exercise, sleep, stress management, nutrition, lifestyle
Eligibility Criteria
You may qualify if:
- Able to read/understand English
- Normal performance using standardized cognitive tests
- Self-reported decline in cognitive capacity such as memory loss
- Eligible for non-invasive fMRI
- Willing to be randomized
- Free of any severe psychiatric diagnoses or medication that may affect participation
You may not qualify if:
- Medical disorders or medications that affect the central and autonomic nervous system; or a positive pregnancy test result (females)
- Unable to provide consent or understand study procedures due to mental illness or cognitive limitations
- Previous meditation experiences
- Evidence of illicit drug use
- Participants for blood draws weigh less than 110 lbs
- Metal or metallic materials in the body such as pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arizona State University
Phoenix, Arizona, 85004, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Yi-Yuan Tang
- Organization
- Arizona State University
Study Officials
- PRINCIPAL INVESTIGATOR
YiYuan Tang
Arizona State University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2022
First Posted
July 7, 2022
Study Start
February 1, 2021
Primary Completion
February 28, 2023
Study Completion
February 28, 2023
Last Updated
October 29, 2024
Results First Posted
October 29, 2024
Record last verified: 2024-10